| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 2.40M | — |
| Operating expense | — | — |
| Net income | -15.77M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, PRQR returned +4.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +16.8% |
| 1 year | +4.4% |
| 5 years | -64.7% |
| 10 years | -59.8% |
| All-time high | $21.88 (Mar 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in PRQR would be worth today ›No. ProQR Therapeutics N.V. has not paid a dividend in the past 12 months.
ProQR Therapeutics N.V. stock trades on NASDAQ under the ticker symbol PRQR.
ProQR Therapeutics N.V. is part of the Healthcare sector.
ProQR Therapeutics N.V. has a market cap of 333.04M USD, based on the latest quote.
ProQR Therapeutics N.V. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
